chrisvoncsefalvay/vaers-outcomes huggingface dataset:
shaking chills; temp of 101.4 at 2:00 pm; sudden onset extreme fatigue; This is a spontaneous report from a contactable Nurse reported for herself. A 63-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), Intramuscular at Left arm on 13Jan2021 10:15 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at clinic. Medical history included chronic cerebrospinal fluid leakage (CSF) Leak, intraductal papillary mucinous neoplasm (IPMN) pancreatic lesion, chronic thyroiditis with large nodule, mitral valve prolapse, osteoporosis, multiple breast fibroadenomas, timalleolar fracture, ankle, and prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included lansoprazole, tramadol, potassium citrate, ASA and "Vi".  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced sudden onset extreme fatigue at 1:00 pm on 14Jan2021 followed by shaking chills and temperature of 101.4 at 2:00 pm. No treatment received for the events. Since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was unknown.
I began having strange heart palpitations in the late afternoon, 5 days after receiving the vaccine. On the morning of the 6th day, I had an elevated heart rate, chest tightness and shortness of breath. It was difficult to have a conversation without having to constantly stop to take a deep breath, to ?catch up.? My lungs felt like they had substantially less capacity with a deep breath than before the symptoms presented. I had extreme fatigue, joint and muscle pain. On the 7th day, I woke up with the same symptoms, and decided to go back to bed due to continues extreme fatigue. After waking up, I felt somewhat better, until later in the evening, when all the aforementioned symptoms came back. The following morning (8th day) I felt much better, and decided to go on a mountain bike ride to see how my heart and breathing felt. I noticed some decreased cardiovascular performance, but not as bad as the previous days. Later that evening, the shortness of breath and elevated heart rate came back. On the 9th day, the elevated heart rate was noticeably better, and the shortness of breath was still present, but not as bad as before. My blood pressure remained elevated and I have been unable to get it below 135/80 range. Same issues on the 10th day. Today, on the 11th day, I attempted to go run and found that my cardiovascular conditioning was the worst I have ever experienced in my life, without exaggeration. I had difficulty with a pace and duration that I would normally complete with ease before being vaccinated. I had to cut it short, as I was having difficulty breathing and my lungs were burning. I hope that these symptoms subside and are not permanent. I was hesitant to get the vaccine for a very long time, but decided to do it based of off removal of the mask mandates for vaccinated personnel. If I could go back knowing I would feel this way, I would never have allowed this vaccine to be injected in my body. I am a healthy, athletic 31 year old male, and now I feel like I am in the worst shape of my life. I feel awful.
*Please note, on the day of the vaccine (January 14th)  about 7pm I experienced severe body pain, cold clammy sweat, nausea, dizzy, and sleepiness.  I THOUGHT I was having a blood sugar issue, but that was not the case.  I went to sleep for about two hours, then woke up about 9pm feeling a little better.  I had NO pain in my arm or anywhere else and slept the entire night.    Friday (1/22), I developed pain and swelling in my breast, armpit, and injection site.  I literally  felt crappy all weekend.  Weird...????  I was confused this happened about ONE WEEK AFTER the vaccine. The injection site was the size of a golf ball, hard, and  quite warm.  I began to feel better after about 3 days, but the arm was still slightly red, sore, and there's a slight bump.
Swollen lower lip-starting on the left corner Swollen Left Side Cheek and Jaw White sensitive bumps on tongue Getting worse each day. Today is Friday 4/23/2021
I got the 1st Moderna vaccine, Feb 8, 2021 (left arm). A red itchy rash began on my left arm Feb15, and got worse, forming a large red triangle (left arm). My arm was swollen, hot, red, very itchy. It lasted a week and slowly went away. I got the 2nd Moderna vaccine for COVID 19, on Mar 9, at 3:45 pm, (left arm). March 10th at 10:00 am. I got a fever and cold chills in the day and evening. After reaching 100.8 degrees, I took tylenol and was able to sleep. I had a red itchy rash already on my left arm which began on Mar 10th. On Mar 17 I woke with a swollen lymph node on my left collar bone area under my thyroid (left). It has continued and has spread to my mid-neck.I feel tired and it hurts to swallow.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022; No adverse event; Patient administered the vaccine after the 30 day by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 69-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 23-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 23-Jul-2022).    No concomitant product use was reported.  Patient received half dose.  Vial did not undergone any temperature excursions.  No treatment information was provided.
Injection site- rash, red in color, about 3 inches in diameter, itching
Patient received first dose on 10/4/21.  She said after receiving the shot later in the day she had hand numbness for 1 to 2 weeks. She told us when she came in for her second dose today 10/25/21.
Pt. states that after receiving the 2nd dose of Moderna 03/11/2021, started experiencing symptoms 03/26/2021 of pain in the right leg resulting in several Blood Clots in the right leg. Ortho confirmed and prescribed Xarelto.
Sitting in chair after vaccines and said "I don't feel good."  Head drooped, patient's eyes rolled back and arms started shaking.  Patient became syncopal.  Laid down, drank juice.  Patient states that she did not eat that day.  Ok to ambulance.
dizziness; headache; nauseous; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID. The reporter is the patient.  An 82-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Sep2023 as dose number unknown, single (Batch/Lot number: unknown) at the age of 82 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset Sep2023, outcome "unknown"; HEADACHE (non-serious) with onset Sep2023, outcome "unknown"; NAUSEA (non-serious) with onset Sep2023, outcome "unknown", described as "nauseous".  Additional information: The patient had the vaccine shot Thursday afternoon and she had symptoms of headache and dizziness. When the patient got dizzy, the patient got nauseas at the same time and the patient had been lying down for 4 days. The patient didn't have this before so she wanted to know if this was from the shot or should she go to the doctor. The patient couldn't even get up to go to the doctor. The patient asked how long do the side effects last and if there was any data on the maximum time the side effects last. The reporter also asked for treatment recommendations.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Implanted device fired after minimal exertion.  followed 4 days later by another firing, 1 week later experienced a v-tek storm where defribulator fired 16X requiring emergency room and hospital stay for 1 week where cardiac ablation was performed.  Inflamation of heart and electrical problems have persisted with arithmias still ocurring even after administration of anti arithmia drugs.  Will more than likely require additional ablation in 2 to 3 months.
On day 6 my arm begin to be sore again just like when I received the vaccine. It was sore for about 3 days. It was also red, warm, and swollen.  On day 7 I noticed a rash on my arm at the injection site. It began to spread down my arm. There has also been itching too.  I am now on steroids on day 2 of the pack. Rash has began lighten some and swelling and warmth has resolved still itching.
mild headache several hours after shot along with fatigue.  At 6:00 PM that day, starting experiencing chills and mild temperature (99.5).  Chills got worse all night and fever spiked to almost 104 degrees.  Uncontrollable chills along with body aches and nausea until fever broke around 5:00 AM.  By 9:00 AM fever was back down and felt achy and tired for the remainder of the day and into the night.
This spontaneous report was received from a pharmacist referring to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions or pertinent medical history were not reported. On an unknown date, the patients were vaccinated with improperly stored doses VARIVAX, lot # M02338 with expiration date 11-MAY-2018 (dose, frequency and route of administration were unspecified) for prophylaxis. No adverse effects were reported. It was stated that the vaccines were exposure to a temperature greater than 14 but lower than 46 Fahrenheit degrees for a time frame of 2 hours and 30 minutes. It was also reported that there was a previous exposure to the same temperature for a time frame of 12 hours. The report was due to a data logger. This is one of two reports from the same reporter 1702USA009210. Additional information is not expected since the reported refused to be contacted.; Sender's Comments: US-009507513-1702USA009210:
On 2/21/18, patient was given SHINGRIX vaccine that was mixed with the sterile diluent (instead of the adjuvant diluent that comes from the manufacturer). We called the manufacturer to report this discrepancy and they told us if SHINGRIX is reconstituted with anything other than adjuvant suspension diluent, the dose will not be effective. We need to repeat the first dose immediately and may give the second dose between (2-6 months as per regular interval), so patient gets an effective dose.
Initial information received on 05-Jul-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a two months old male patient who experienced expired PENTACEL was administered, while he received vaccine PENTACEL. The patient past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 02-Jul-2018, the patient received a first dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot C5385AA via unknown route in left leg. On an unknown date, (Unknown latency period), of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE the patient had expired pentacel was administered. Final diagnosis was expired pentacel was administered. It was not reported if the patient received a corrective treatment. The patient outcome reported as Not Applicable. Documents held by sender: none.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider, a pharmacist, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2012, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 18-NOV-2016, the patient was treated by a nurse practitioner for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the her injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Severe body aches, crying, back pain, fever to 102F, headache, nausea.  Patient recovered spontaneously after 2-3 days.
Information has been received from a medical sales service distributor, concerning a female patient (age not specified), who was vaccinated (date not reported) with a dose of pneumococcal 23v polysaccharide vaccine (lot #655501/1035F). Later on the day of vaccination, the patient developed severe cellulitis and was hospitalized for an unspecified duration of time. At the time of this report, the outcome of the event was unknown. No further information was available. Additional information has been requested.
Extreme soreness two weeks later. Sharp pains when lifting arm. The pain is keeping me awake at night.
Immunizations given.  Mom brought child back to clinic within 5 minutes with pruritic skin, welts on back and shoulders.  No breathing difficulties.  Hydrocortisone cream applicant and 5mL of Benadryl Elixer given per mouth.  Child left and 10 min and appeared and said he was "fine."
swollen arm after second shot; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm after second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm after second shot). At the time of the report, PERIPHERAL SWELLING (swollen arm after second shot) outcome was unknown.            No concomitant medications were reported. No treatment medication was reported.
Rash / rash on the side of the body and on stomach; This case was reported by a pharmacist via call center representative and described the occurrence of rash in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was captured as adult as per Shingrix indication.  The patient experienced rash on the side of the body and on the stomach after a Shingrix injection. No other details were known at time of report. The reporter was very busy and could not continue with report.  The reporter was reporting what the patient said. The reporter consented to follow up.
Initial report received from a healthcare professional on 17 October 2013. A 05-year-old female patient had received an intramuscular dose of FLUZONE, batch number U4780AA, dose number was not reported in right deltoid on 14 October 2013. The patient has allergy of Penicillin, bananas, nuts and soy. And received DECADRON injection on 16 October 2013. On 17 October 2013, three day after vaccination, the patient experienced redness and rash around injection site. On 17 October 2013 the physician and prescribed ZYRTEC and prednisone. Laboratory investigations were not reported. At the time of this report, the outcome of the events was unknown. Documents held by sender: none. Follow-up information received from a healthcare professional on 12 August 2014. No new information was reported. Documents held by sender:  None.
About 12 hours after injection, extreme chills and high fever. High fever of 104.1. After about 16 hours, throwing up and tons of pain shooting the body. Fever averaged about 102 for about 18 hours then dropped to 101. Continual dry heaving with copious amount of muscle pains. Muscles would continue to tense up and feel like lava was flowing through my veins. 48 hours later still with adverse events going on.
Tenderness/ Pain  on site of the injection for over 48 hours. Feeling un-well for 24 hours. Stomach ache, muscle aches, weakness, fatigue.
Left arm pain after shot given and then 2 weeks later still have left arm pain that did travel to the left side of her back.
G47.33 OBSTRUCTIVE SLEEP APNEA 4/15/2023 ALCOHOLIC FATTY LIVER
Pediatric Hep A administered; Adult Hep A ordered.  Will have patient return to clinic to receive Adult Hep A  vaccine.  No adverse signs/symptoms. Vaccine administered by MA
Myalgia chills Narrative:  chills and sore arm for 2 days with 1st vaccine  Other Relevant History:
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date the patient was inadvertently vaccinated with a second dose of ZOSTAVAX (lot number and exp. date not provided) (strength, dose, frequency and route not provided). No adverse effects were reported. Additional information has been requested.
Headache; Fatigue; This is a spontaneous report from a contactable physician. A 59-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Batch/Lot Number: Unknown), dose 2 via an unspecified route of administration, administered in arm left on 26Mar2021(at the age of 59 years old) as 2nd dose, single dose for covid-19 immunisation. The patient medical history included cardiac disorder from an unknown date and unknown if ongoing. The patient received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient does not have any allergies to medications, food, or other products. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Batch/Lot Number: Unknown) via unspecified route of administration in left arm, administered on 05Mar2021 at 12:00 for covid-19 immunisation. On 27Mar2021 at 13:00, the patient experienced headache and fatigue. No treatment was received for the adverse events. The reporter classified the events as non-serious. The outcome of the events was resolving.  Follow-up (11May2021) was processed as non-significant: No new information was reported.  Follow-up attempts completed. No further information expected.
8 weeks following this vaccination I developed very very mild COVID symptoms, 3 days after my husband developed a severe case of COVID-19 on Dec. 3, 2022.  His COVID symptoms occurred 3 days after we flew. I did not test positive for COVID at that time. I did not even think I had COVID. My husband received Paxlovid 24 hours after he developed symptoms (Dec. 3, Dec. 4) and appeared to be sufficiently recovered to fly home on Sat, Dec,  10,  2022, with no symptoms, fever, etc.  I still tested negative for COVID Dec. 8 but had a slight cough and was tired.   After flying home on Dec. 10, I developed severe COVID symptoms on Sunday, Dec. 11, 2022: heavy congested in my head, a sore throat and aching, plugged up ears, eventually a strong cough and upper respiratory congestion. I tested positive for COVID at this time (home test). My husband also became I?ll that same day with the same symptoms.  We did NOT develop fevers.  We were very sick for 2 weeks. (Dec. 11-24)
Booster; I had all the Pfizer shots for the covid. But guess what? I got the Covid.; I had all the Pfizer shots for the covid. But guess what? I got the Covid.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "I had all the Pfizer shots for the covid. But guess what? I got the Covid.". The lot number for bnt162b2 was not provided and will be requested during follow up.
Case number PHEH2015US025191, is an initial spontaneous report received from a medical assistant on 01 Dec 2015. This report refers to a 35-year-old female patient. Past medical history and concomitant medication was not reported. The patient was vaccinated with FLUVIRIN (batch number: 173538) at a dose of 0.5 ml intramuscularly on 16 Oct 2015 which was stored out of temperature range first time at 32 Fahrenheit and second time at 48.7 Fahrenheit. No adverse event was reported. Following this medication error.
Different taste in mouth immediately, left side of tongue began to go numb, then within 30 min both tongue & throat on left side numb for 15 hours.
Information has been received from a healthcare worker (certified medical Assistant (C.M.A)) concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 19-FEB-2015, the patient was administered with a dose of improperly stored ZOSTAVAX (lot#, expiration date and dose not provided), subcutaneously. No adverse effects were reported. This is one of several reports received form the same source. Additional information has been requested.
Varivax injection on 10-15-07 in R arm SC.  Redness & swelling x2d with subsequent office visit on 10-17-07.